Hongxiang Hu

Also affiliated with Sichuan University, University of Michigan, West China Hospital of Sichuan University, Bristol-Myers Squibb (United States), Bristol-Myers Squibb (Sweden)

MedicineImmunology and MicrobiologyMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice”.

Albumin nanoparticle containing a PI3Kγ inhibitor and paclitaxel in combination with α-PD1 induces tumor remission of breast cancer in mice

Science Translational Medicine(2022)10.1126/scitranslmed.abl3649

N/A

0DataRank · unranked

132 citations

Luke F. Bugada, Ruiting Li, Hongxiang Hu, Luchen Zhang, Chengyi Li +7 more

Antigen-Clustered Nanovaccine Achieves Long-Term Tumor Remission by Promoting B/CD 4 T Cell Crosstalk

ACS Nano(2024)10.1021/acsnano.3c13038

N/A

0DataRank · unranked

22 citations

Ryan M. Clauson, Luke F. Bugada, Fang Ke, Bing He, Zhixin Yu +19 more